Nutraceuticals and their role in tumor angiogenesis

Exp Cell Res. 2021 Nov 15;408(2):112859. doi: 10.1016/j.yexcr.2021.112859. Epub 2021 Oct 9.

Abstract

Angiogenesis plays a pivotal role in cancer initiation, maintenance, and progression. Diet may inhibit, retard or reverse these processes affecting angiogenesis (angioprevention). Nutraceuticals, such as omega-3 fatty acids, amino acids, proteins, vitamins, minerals, fibers, and phenolic compounds, improve health benefits as they are a source of bioactive compounds that, among other effects, can regulate angiogenesis. The literature concerning the pro-angiogenic and/or anti-angiogenic nutraceuticals and the possible activated pathways in cancer and other non-neoplastic diseases by in vivo and in vitro experiments are reviewed.

Keywords: Angiogenesis; Anti-Angiogenesis; Nutraceuticals; Tumor growth.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Dietary Supplements*
  • Humans
  • Immunotherapy*
  • Neoplasms / diet therapy*
  • Neoplasms / drug therapy
  • Neoplasms / immunology
  • Neoplasms / pathology
  • Neovascularization, Pathologic / diet therapy*
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / immunology
  • Neovascularization, Pathologic / pathology

Substances

  • Angiogenesis Inhibitors